“This is Beyond Shocking” – American Frontline Doctors on FDA Approval of Failed Ebola Drug Remdesivir By the FDA for “Treatment” of Covid-19 in Babies

On April 25, 2022, the failed Ebola drug Remdesivir was approved by the FDA for “treatment” of Covid-19 in babies as young as 28 days old and as small as seven pounds! 

This is the exact same drug that has been wreaking carnage throughout hospitals since Fauci and Company approved the rigid CARES Act hospital protocol, along with bonus payments for treatment of Covid-19 with Remdesivir. 

This is beyond shocking. 

Repeatedly, Remdesivir has been shown to be completely ineffective at treating Covid-19 in adults (even WHO studies show this) and to have severe side effects, including multiple organ dysfunction syndrome (MODS), kidney failure and dialysis, and septic shock.

GRTWT.